These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16721032)

  • 1. Efficient human interferon-alpha gene transfer to neuroendocrine tumor cells with long-term and stable expression.
    Liu M; Kilarski WW; Gerwins P; Oberg K; Zhou Y
    Neuroendocrinology; 2005; 82(5-6):264-73. PubMed ID: 16721032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfer of vasostatin, a calreticulin fragment, into neuroendocrine tumor cells results in enhanced malignant behavior.
    Liu M; Imam H; Oberg K; Zhou Y
    Neuroendocrinology; 2005; 82(1):1-10. PubMed ID: 16293970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
    Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A defective retroviral vector encoding human interferon-alpha2 can transduce human leukemic cell lines.
    Austruy E; Bagnis C; Carbuccia N; Maroc C; Birg F; Dubreuil P; Mannoni P; Chabannon C
    Cancer Gene Ther; 1998; 5(4):247-56. PubMed ID: 9694076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression and antitumor effect following im electroporation delivery of human interferon alpha 2 gene.
    Zhang GH; Tan XF; Shen D; Zhao SY; Shi YL; Jin CK; Sun WG; Guo YH; Chen KH; Tang J
    Acta Pharmacol Sin; 2003 Sep; 24(9):891-6. PubMed ID: 12956937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells.
    Vitale G; van Koetsveld PM; de Herder WW; van der Wansem K; Janssen JA; Colao A; Lombardi G; Lamberts SW; Hofland LJ
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E559-66. PubMed ID: 19141687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects on melanoma and immunological mechanism of human interferon-alpha gene therapy by fibroblasts].
    Chen M; Lin Z; Cao X
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 Sep; 16(5):298-301. PubMed ID: 11593666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
    Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
    Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-2 promotes disease progression of neuroendocrine tumors.
    Detjen KM; Rieke S; Deters A; Schulz P; Rexin A; Vollmer S; Hauff P; Wiedenmann B; Pavel M; Scholz A
    Clin Cancer Res; 2010 Jan; 16(2):420-9. PubMed ID: 20068079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Up-regulation of thymidine phosphorylase and anti-angiogenesis by interferon alpha in human hepatocellular carcinoma cell line and xenograft].
    Xiao YS; Zhou J; Tang ZY; Fan J; Wu ZQ; Liu YK; Ye SL; Shen ZZ; Xue Q; Zhao Y
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3205-9. PubMed ID: 16405841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha gene therapy in combination with CD80 transduction reduces tumorigenicity and growth of established tumor in poorly immunogenic tumor models.
    Hiroishi K; Tüting T; Tahara H; Lotze MT
    Gene Ther; 1999 Dec; 6(12):1988-94. PubMed ID: 10637450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma.
    Hamner JB; Sims TL; Cutshaw A; Dickson PV; Rosati S; McGee M; Ng CY; Davidoff AM
    J Pediatr Surg; 2008 Jan; 43(1):177-82; discussion 182-3. PubMed ID: 18206478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
    Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
    J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KRJ-I and BON cell lines: defining an appropriate enterochromaffin cell neuroendocrine tumor model.
    Siddique ZL; Drozdov I; Floch J; Gustafsson BI; Stunes K; Pfragner R; Kidd M; Modlin IM
    Neuroendocrinology; 2009; 89(4):458-70. PubMed ID: 19295186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells.
    Ferrantini M; Proietti E; Santodonato L; Gabriele L; Peretti M; Plavec I; Meyer F; Kaido T; Gresser I; Belardelli F
    Cancer Res; 1993 Mar; 53(5):1107-12. PubMed ID: 8439955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
    Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
    Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.
    Santodonato L; D'Agostino G; Santini SM; Carlei D; Musiani P; Modesti A; Signorelli P; Belardelli F; Ferrantini M
    Gene Ther; 1997 Nov; 4(11):1246-55. PubMed ID: 9425449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice.
    Lee J; Wang A; Hu Q; Lu S; Dong Z
    Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.